Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Cogent Biosciences, Inc. per 2025 Jun 30 adalah -299.66 MM.
- Nilai net income untuk Cogent Biosciences, Inc. per 2025 Jun 30 adalah -284.08 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -299.66 | -284.08 | |
2025-03-31 | -288.47 | -269.50 | |
2024-12-31 | -275.94 | -255.86 | |
2024-09-30 | -260.43 | -242.30 | |
2024-06-30 | -244.60 | -227.04 | |
2024-03-31 | -227.30 | -212.17 | |
2023-12-31 | -208.13 | -192.41 | |
2023-09-30 | -193.65 | -177.66 | |
2023-06-30 | -170.89 | -157.34 | |
2023-03-31 | -159.66 | -148.19 | |
2022-12-31 | -147.84 | -140.24 | |
2022-09-30 | -129.73 | -125.53 | |
2022-06-30 | -112.73 | -109.56 | |
2022-03-31 | -94.17 | -91.18 | |
2021-12-31 | -75.55 | -72.27 | |
2021-09-30 | 0.00 | -61.37 | -58.70 |
2021-06-30 | 0.31 | -51.84 | -89.60 |
2021-03-31 | 0.84 | -41.95 | -80.44 |
2020-12-31 | 7.87 | -35.29 | -74.81 |
2020-09-30 | 23.16 | -21.59 | -61.17 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk Cogent Biosciences, Inc. pada 2025 Jun 30 adalah -2.52.
- laba per saham yang terdilusi untuk Cogent Biosciences, Inc. pada 2025 Jun 30 adalah -2.52.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | -2.52 | -2.52 |
2025-03-31 | -2.04 | -2.04 |
2024-12-31 | -2.46 | -2.46 |
2024-09-30 | -2.48 | -2.48 |
2024-06-30 | -2.47 | -2.47 |
2024-03-31 | -3.42 | -3.42 |
2023-12-31 | -2.41 | -2.41 |
2023-09-30 | -2.35 | -2.35 |
2023-06-30 | -2.20 | -2.20 |
2023-03-31 | -2.27 | -2.27 |
2022-12-31 | -2.38 | -2.38 |
2022-09-30 | -2.44 | -2.44 |
2022-06-30 | -2.49 | -2.49 |
2022-03-31 | -2.21 | -2.21 |
2021-12-31 | -1.87 | |
2021-09-30 | -4.93 | -4.93 |
2021-06-30 | -7.58 | -7.58 |
2021-03-31 | -10.32 | -10.32 |
2020-12-31 | -16.17 | |
2020-09-30 | -7.45 | -7.45 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Cogent Biosciences, Inc. per 2025 Jun 30 adalah -233.61 MM.
- Nilai cash from investing activities untuk Cogent Biosciences, Inc. per 2025 Jun 30 adalah 200.15 MM.
- Nilai kas dari aktivitas pendanaan untuk Cogent Biosciences, Inc. per 2025 Jun 30 adalah 72.85 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -233.61 | 200.15 | 72.85 |
2025-03-31 | -221.77 | 106.61 | 25.36 |
2024-12-31 | -207.79 | 38.28 | 214.45 |
2024-09-30 | -191.28 | -12.91 | 214.43 |
2024-06-30 | -177.27 | -163.63 | 214.80 |
2024-03-31 | -166.64 | -156.66 | 377.15 |
2023-12-31 | -153.62 | -97.82 | 163.54 |
2023-09-30 | -138.96 | -79.90 | 163.85 |
2023-06-30 | -135.43 | -140.91 | 163.84 |
2023-03-31 | -129.82 | -64.39 | 163.87 |
2022-12-31 | -118.64 | -124.72 | 163.56 |
2022-09-30 | -110.01 | -153.56 | 201.25 |
2022-06-30 | -89.68 | -3.18 | 200.31 |
2022-03-31 | -75.73 | -2.16 | 38.20 |
2021-12-31 | -58.76 | -1.72 | 37.98 |
2021-09-30 | -47.35 | -1.29 | 122.11 |
2021-06-30 | -43.51 | 8.30 | 231.98 |
2021-03-31 | -39.32 | 8.42 | 232.04 |
2020-12-31 | -35.85 | 8.42 | 232.20 |
2020-09-30 | -34.93 | 8.41 | 110.06 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk Cogent Biosciences, Inc. pada 2025 Jun 30 adalah 3.73.
- p/tbv untuk Cogent Biosciences, Inc. pada 2025 Jun 30 adalah 7.38.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 3.73 | 7.38 | |
2025-03-31 | 2.79 | 2.79 | |
2024-12-31 | 2.71 | 2.71 | |
2024-09-30 | -5.25 | 3.20 | 3.20 |
2024-06-30 | -3.80 | 1.91 | 1.91 |
2024-03-31 | -3.52 | 2.63 | 2.63 |
2023-12-31 | -2.86 | 1.46 | 1.46 |
2023-09-30 | -5.30 | 2.39 | 2.39 |
2023-06-30 | -5.54 | 3.67 | 3.67 |
2023-03-31 | -5.39 | 2.95 | |
2022-12-31 | 2.79 | 2.79 | |
2022-09-30 | 3.07 | 3.07 | |
2022-06-30 | -8.70 | 4.22 | 4.22 |
2022-03-31 | -4.75 | 1.60 | 1.60 |
2021-12-31 | -5.83 | 1.73 | 1.73 |
2021-09-30 | -3.74 | 1.58 | 1.58 |
2021-06-30 | |||
2021-03-31 | -3.27 | 1.16 | 1.16 |
2020-12-31 | -3.06 | 0.98 | 0.98 |
2020-09-30 | -1.24 | 0.65 | 0.65 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Cogent Biosciences, Inc. pada 2025 Jun 30 adalah -0.34.
- EBIT (3 tahun) / EV untuk Cogent Biosciences, Inc. pada 2025 Jun 30 adalah -0.27.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.34 | -0.27 |
2025-03-31 | -0.35 | -0.28 |
2024-12-31 | -0.28 | -0.22 |
2024-09-30 | -0.19 | -0.15 |
2024-06-30 | -0.26 | -0.19 |
2024-03-31 | -0.28 | -0.20 |
2023-12-31 | -0.37 | -0.25 |
2023-09-30 | -0.23 | -0.17 |
2023-06-30 | -0.21 | -0.16 |
2023-03-31 | -0.21 | -0.15 |
2022-12-31 | -0.17 | -0.11 |
2022-09-30 | -0.15 | -0.11 |
2022-06-30 | -0.13 | -0.10 |
2022-03-31 | -0.35 | -0.29 |
2021-12-31 | -0.26 | -0.25 |
2021-09-30 | -0.44 | -0.25 |
2021-06-30 | ||
2021-03-31 | -0.63 | -0.28 |
2020-12-31 | -0.77 | -0.36 |
2020-09-30 | -0.72 | -0.24 |
Efektivitas Manajemen
- roa untuk Cogent Biosciences, Inc. pada 2025 Jun 30 adalah -0.63.
- roe untuk Cogent Biosciences, Inc. pada 2025 Jun 30 adalah -0.72.
- roic untuk Cogent Biosciences, Inc. pada 2025 Jun 30 adalah -1.14.
- croic untuk Cogent Biosciences, Inc. pada 2025 Jun 30 adalah -0.38.
- ocroic untuk Cogent Biosciences, Inc. pada 2025 Jun 30 adalah -0.94.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.63 | -0.72 | -1.14 | -0.38 | -0.94 |
2025-03-31 | -0.54 | -0.61 | -0.93 | 0.16 | -0.76 |
2024-12-31 | -0.77 | -0.94 | -0.73 | 0.03 | -0.58 |
2024-09-30 | -0.64 | -0.65 | -0.58 | -0.32 | -0.45 |
2024-06-30 | -0.81 | -0.95 | -0.48 | 0.12 | -0.38 |
2024-03-31 | -0.64 | -0.75 | -0.70 | -0.32 | -0.56 |
2023-12-31 | -0.54 | -0.61 | -0.48 | -0.15 | -0.38 |
2023-09-30 | -0.43 | -0.49 | -0.43 | -0.31 | -0.37 |
2023-06-30 | -0.40 | -0.46 | -0.43 | -0.31 | -0.37 |
2023-03-31 | -0.68 | -0.75 | -0.61 | -0.12 | -0.53 |
2022-12-31 | -0.58 | -0.64 | -0.40 | -0.20 | -0.35 |
2022-09-30 | -0.51 | -0.56 | -0.40 | -0.20 | -0.35 |
2022-06-30 | -0.40 | -0.43 | -0.32 | 0.31 | -0.26 |
2022-03-31 | -0.30 | -0.32 | -0.48 | -0.21 | -0.40 |
2021-12-31 | -0.23 | -0.25 | -0.33 | -0.10 | -0.24 |
2021-09-30 | -0.64 | -0.77 | -0.29 | 0.37 | -0.20 |
2021-06-30 | -1.81 | -2.82 | -0.41 | 0.91 | -0.20 |
2021-03-31 | -1.63 | -2.53 | -0.35 | 0.87 | -0.17 |
2020-12-31 | 0.01 | 0.01 | -0.31 | 0.85 | -0.15 |
2020-09-30 | -0.50 | 0.69 | -0.29 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | -94.55 | ||
2021-06-30 | -94.55 | -287.17 | -152.68 |
2021-03-31 | -25.85 | -95.76 | -49.94 |
2020-12-31 | -2.27 | -9.50 | -4.48 |
2020-09-30 | -0.22 | -2.64 | -0.82 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1622229 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |